Correlations exist between serum soluble transferrin receptor, cardiac function, and exercise tolerance in HFpEF, suggesting its role in outcome prediction.
Serum sTfR correlates with HFpEF severity and prognosis, offering a potential biomarker for disease assessment and outcome prediction.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: